Us Congress House Bill HB1992

Us Congress 2023-2024 Regular Session

• Introduced: 3/29/23
• Refer: 3/29/23
• Refer: 4/7/23

Caption

To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Human Genome Research for fiscal year 2024.

Impact

The limitation imposed by HB1992 may have significant ramifications on the pace and scope of human genome research initiatives, which are integral to advancements in personalized medicine, disease understanding, and potentially groundbreaking therapeutic innovations. Advocates for genome research argue that such funding restrictions might hinder the progress of vital public health research at a time when understanding human genetics is becoming increasingly crucial for effective healthcare solutions. On the other hand, proponents of the bill may argue from a fiscal responsibility standpoint, suggesting that limiting funds can promote more efficient allocation of taxpayer resources.

Summary

House Bill 1992 proposes a funding limitation for the Department of Health and Human Services (HHS), specifically targeting the National Human Genome Research conducted by the National Institutes of Health (NIH) for the fiscal year 2024. The bill states that the funds appropriated for this research shall not exceed $575,579,000. This is a crucial piece of legislation as it delineates a cap on federal spending for genetic research, which can have substantial implications for ongoing and future projects in this vital area of science and health.

Contention

Discussion around this bill may pivot on the balance between fiscal prudence and the necessity of investing in scientific research. While supporters of HB1992 may frame their argument around the efficient use of government funding, opponents might assert that constraining resources to such a pivotal area could jeopardize public health advancements and the United States' global leadership in biomedical research. As genome research increasingly shapes the landscape of healthcare, the implications of the funding cap outlined in this bill will likely spur debate within both the legislative arena and the broader public discourse.